Endocrine Society GUIDELINES Bundle (free trial)

Primary Aldosteronism

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1140172

Contents of this Issue

Navigation

Page 3 of 13

Diagnosis 4 Figure 1. Algorithm for the Detection, Confirmation, Subtype Testing, and Treatment of PA Patients with Hypertension that are at Increased Risk for PA Treat with MR Antagonist (1|⊕⊕⊕ ) Confirmatory Testing (1|⊕⊕ ) a ES recommends unilateral laparoscopic adrenalectomy for patients with documented unilateral PA (ie, APA or UAH) (1|⊕⊕⊕ ). If a patient is unable or unwilling to undergo surgery, ES recommends medical treatment including a MR antagonist (1|⊕⊕ ). If an ARR-positive patient is unwilling or unable to undergo further investigations, ES similarly recommends medical treatment including an MR antagonist (1|⊕⊕ ). b Instead of proceeding directly to subtype classification, ES recommends that patients with a positive ARR undergo one or more confirmatory tests to definitively confirm or exclude the diagnosis (1|⊕⊕ ). However, in the setting of spontaneous hypokalemia, undetectable renin, and PAC >20 ng/dL (550 pmol/L), ES suggests that there may be no need for further confirmatory testing (2|⊕ ). c ES recommends that when surgical treatment is feasible and desired by the patient, an experienced radiologist should use AVS to make the distinction between unilateral and bilateral adrenal disease (1|⊕⊕⊕ ). Younger patients (20 ng/dL ARR to Detect Cases (1|⊕⊕ ) Subtype Testing

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Primary Aldosteronism